IL189459A - Use of triazole history to prepare a drug for the treatment and prevention of disease, a number of such history and a pharmaceutical composition containing a number of these - Google Patents
Use of triazole history to prepare a drug for the treatment and prevention of disease, a number of such history and a pharmaceutical composition containing a number of theseInfo
- Publication number
- IL189459A IL189459A IL189459A IL18945908A IL189459A IL 189459 A IL189459 A IL 189459A IL 189459 A IL189459 A IL 189459A IL 18945908 A IL18945908 A IL 18945908A IL 189459 A IL189459 A IL 189459A
- Authority
- IL
- Israel
- Prior art keywords
- compounds
- prophylaxis
- medicament
- disorders
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US70794105P | 2005-08-15 | 2005-08-15 | |
| EP05017732A EP1757290A1 (en) | 2005-08-16 | 2005-08-16 | Novel triazole derivatives as ghrelin analogue ligands of growth hormone secretagogue receptors |
| US78754306P | 2006-03-31 | 2006-03-31 | |
| PCT/EP2006/007945 WO2007020013A2 (en) | 2005-08-15 | 2006-08-11 | Novel triazole derivatives as ghrelin analogue ligands of growth hormone secretagogue receptors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL189459A0 IL189459A0 (en) | 2008-12-29 |
| IL189459A true IL189459A (en) | 2015-08-31 |
Family
ID=41168847
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL189459A IL189459A (en) | 2005-08-15 | 2008-02-12 | Use of triazole history to prepare a drug for the treatment and prevention of disease, a number of such history and a pharmaceutical composition containing a number of these |
Country Status (4)
| Country | Link |
|---|---|
| HK (1) | HK1121681A1 (no) |
| IL (1) | IL189459A (no) |
| NO (1) | NO342380B1 (no) |
| RU (1) | RU2415134C9 (no) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016130901A2 (en) * | 2015-02-12 | 2016-08-18 | University Of Southern California | Blockers of the growth hormone receptor in disease prevention and treatment |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6518292B1 (en) * | 1999-03-12 | 2003-02-11 | Bristol-Myers Squibb Co. | Heterocyclic aromatic compounds usefuls as growth hormone secretagogues |
| DE60038498T2 (de) * | 1999-11-15 | 2009-05-07 | Janssen Pharmaceutica N.V. | Triazole als Farnesyltransferaseinhibitoren |
-
2006
- 2006-08-11 RU RU2008109929/04A patent/RU2415134C9/ru active
-
2008
- 2008-02-12 IL IL189459A patent/IL189459A/en active IP Right Grant
- 2008-03-10 NO NO20081248A patent/NO342380B1/no unknown
- 2008-12-04 HK HK08113191.2A patent/HK1121681A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| HK1121681A1 (en) | 2009-04-30 |
| NO20081248L (no) | 2008-05-05 |
| RU2008109929A (ru) | 2009-09-27 |
| NO342380B1 (no) | 2018-05-14 |
| IL189459A0 (en) | 2008-12-29 |
| RU2415134C2 (ru) | 2011-03-27 |
| RU2415134C9 (ru) | 2011-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL183108A (en) | Triazole Compounds, Containing and Using Pharmaceutical Preparations for the Treatment of Prosperity Irregularities | |
| IL184148A (en) | History of triazole is claimed as oxytocin antagonists, their pharmacological preparations and their use in the preparation of drugs for the treatment of disorders in which the inhibition of oxytocin gives a beneficial effect | |
| IL202158A (en) | History of Oxadiazole, Pharmaceuticals Containing Them and Their Use in the manufacture of Drugs for the Treatment of Neurological and Psychiatric Disorders | |
| IL195142A (en) | Processed arylaimidazolone and triazolone, their preparation process, pharmaceutical preparations containing them for the treatment or prevention of diseases | |
| IL192763A (en) | History of pyrimidine, preparations containing them and used in the preparation of cancer drugs | |
| IL189578A (en) | Pyridine derivatives, pharmaceutical compounds containing them, and their use in the preparation of drugs for the treatment of cns diseases | |
| IL179714A (en) | Pharmaceutical preparation containing a history of 2-biphenyl-4-ram-3,2-dehydro-1h-quinazoline-4-on and its use in the preparation of cancer drugs and blood vessel formation | |
| GB0522311D0 (en) | Pharmaceutical compositions for the treatment of pain | |
| IL206296A (en) | History of aminopyrazole, and their medicinal products and their use in the preparation of drugs for the prevention and treatment of diseases | |
| HK1092722A1 (en) | Pharmaceutical compositions and their use for manufacturing the medicament for treating atherosclerosis, dyslipidemias and related conditions | |
| HK1166983A1 (zh) | 包含用於治療疾病或紊亂的化合物的固體形式，其組合物，及其用途 | |
| IL194678A (en) | Kinase inhibitors, pharmaceutical preparations containing them and their uses in the preparation of a drug for the treatment of cancer in mammals | |
| IL193762A (en) | The effective compounds in inhibiting dgat1-related disorders, their medicinal products and their use in the preparation of drugs | |
| IL231576A (en) | Derivatives of adamantyl-acetamide, the pharmaceutical compositions containing them and their use in the preparation of medicines | |
| IL181304A (en) | Use of dihydroprididone for the preparation of a drug for the treatment of spinal cord dysplasia | |
| IL199362A (en) | Pyridopyrimidine Compounds, Pharmaceuticals, Compounds for Use as a Drug, and Compounds for Manufacture @ Drug | |
| IL186303A (en) | 1h - benzamideimzole - 4 carboxyamides converted with quarterly carbon in position 2, the pharmaceutical composition containing it and its use for the preparation of a drug @ for the treatment @ of cancer | |
| IL200212A (en) | Heterocyclic carboxamide compounds, pharmaceuticals containing them, and their use in the manufacture of drugs to treat or reduce the severity or disease of the cancer and arthritis | |
| IL181524A (en) | Heterocyclic compounds, pharmaceuticals containing them and their use in the preparation of drugs | |
| IL206399A (en) | Amino triazole history, a pharmaceutical composition containing them and their use in the preparation of a drug | |
| IL185462A0 (en) | New pharmaceutical compositions useful in the treatment of pain | |
| IL184712A (en) | History of pyrzulo-pyrimidine, process of preparation, medicinal preparations containing them and use of pharmaceutical preparations | |
| WO2006116221A3 (en) | Therapeutic combinations for the treatment or prevention of psychotic disorders | |
| IL202505A (en) | 2-oxo-3-benzyl-benzoxazole-2-one derivatives and related compounds as met kinase inhibitors for the treatment of tumors, drugs containing them and their uses | |
| IL191310A (en) | A variant of the factor xa enhancer hemostasis, a pharmaceutical product containing it, and its use in the preparation of drugs for the treatment of hemostasis-related diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed |